|
Payá E, Marín F, González J, Gimeno JR, Feliu E, Romero A, Ruiz-Espejo F, Roldán V, Climent V, de la Morena G, Valdés M. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications. J Card Fail. 2008 Jun;14(5):414-9. doi: 10.1016/j.cardfail.2008.02.006. Epub 2008 May 27. PubMed PMID: 18514934.
AÑO: 2008; IF: 3.691
|
18514934
|
Roldán V, Marín F, Gimeno JR, Ruiz-Espejo F, González J, Feliu E, García-Honrubia A, Saura D, de la Morena G, Valdés M, Vicente V. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy. Am Heart J. 2008 Jul;156(1):85-91. doi: 10.1016/j.ahj.2008.01.035. PubMed PMID: 18585501.
AÑO: 2008; IF: 4.285
|
|
Roldán V, Marín F, González-Conejero R, García-Honrubia A, Martí S, Alfaro A, Valdés M, Corral J, Lip GY, Vicente V. Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk. Ann Med. 2008;40(7):553-9. doi: 10.1080/07853890802108412. PubMed PMID: 18608122.
AÑO: 2008; IF: 5.435
|
|
Pineda J, Marín F, Marco P, Roldán V, Valencia J, Ruiz-Nodar JM, Sogorb F, Lip GY. Int J Cardiol. 2009 Aug 14;136(2):222-5. doi: 10.1016/j.ijcard.2008.04.020. Epub 2008 Jul 14. PubMed PMID: 18625524.
AÑO: 2009; IF: 3.469
|
|
Manzano-Fernández S, Pastor FJ, Marín F, Cambronero F, Caro C, Pascual-Figal DA, Garrido IP, Pinar E, Valdés M, Lip GY. Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting. Chest. 2008 Sep;134(3):559-67. doi: 10.1378/chest.08-0350. Epub 2008 Jul 18. PubMed PMID: 18641090.
AÑO: 2008; IF: 5.154
|